| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Werewolf Therapeutics, Inc. (HOWL) has 4 insiders with recent SEC Form 4 filings, including 0 buys and 30 sells. HOWL is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 4.78M | $1.68M | - | |
| 10% | 4.78M | $1.68M | - | |
| Dir | 377.2K | $132.4K | -173,515 | |
| 10% | 361.2K | $126.8K | -678,226 |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 7, 2026 | Evnin Luke55 | Director | Sell | 71,054 | $0.65 | $45,882.17 | -1.0% | +55.9% | - | |
| Jan 2, 2026 | Evnin Luke55 | Director | Sell | 78,377 | $0.62 | $48,430.95 | -1.0% | +56.6% | - | |
| Dec 29, 2025 | Evnin Luke55 | Director | Sell | 291,283 | $0.64 | $185,220.79 | -2.1% | +28.3% | - | |
| Dec 17, 2025 | Evnin Luke55 | Director | Sell | 48,171 | $1.08 | $51,950.82 | -0.6% | -18.7% | - | |
| Dec 12, 2025 | Evnin Luke55 | Director | Sell | 82,971 | $1.07 | $88,586.51 | -0.9% | -24.9% | - | |
| Dec 9, 2025 | Evnin Luke55 | Director | Sell | 95,179 | $1.00 | $94,787.25 | -1.0% | -27.5% | - | |
| Dec 4, 2025 | Mpm Bioventures 2014, L.P.67 | Former 10% Owner | Sell | 199,732 | $0.92 | $183,275.38 | -1.4% | -38.8% | - | |
| Dec 4, 2025 | Gadicke Ansbert85 | Former 10% Owner | Sell | 199,732 | $0.92 | $183,275.38 | -1.4% | -38.8% | - | |
| Dec 4, 2025 | Evnin Luke55 | Director | Sell | 128,185 | $0.92 | $117,623.41 | -1.4% | -38.8% | - | |
| Dec 1, 2025 | Gadicke Ansbert85 | 10% Owner | Sell | 60,917 | $0.94 | $57,261.98 | -1.2% | -36.4% | - |